AutoZone, Inc. (NYSE:AZO – Get Free Report) has been assigned a consensus rating of “Buy” from the twenty-four ratings firms that are covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation, seventeen have given a buy recommendation and four have assigned a strong buy recommendation to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $3,821.91.
AZO has been the subject of several research reports. Morgan Stanley raised their price objective on shares of AutoZone from $3,490.00 to $3,750.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 5th. BMO Capital Markets lifted their price target on AutoZone from $3,700.00 to $3,850.00 and gave the stock an “outperform” rating in a report on Wednesday, March 5th. UBS Group upped their price objective on AutoZone from $3,875.00 to $4,025.00 and gave the company a “buy” rating in a report on Wednesday, March 5th. Guggenheim lifted their target price on AutoZone from $3,750.00 to $3,850.00 and gave the stock a “buy” rating in a report on Wednesday, March 5th. Finally, Barclays upped their price target on shares of AutoZone from $3,024.00 to $3,585.00 and gave the company an “overweight” rating in a research note on Thursday, January 9th.
View Our Latest Stock Analysis on AutoZone
Insiders Place Their Bets
Institutional Trading of AutoZone
Several institutional investors have recently added to or reduced their stakes in the stock. GAMMA Investing LLC boosted its stake in shares of AutoZone by 435,031.1% in the 1st quarter. GAMMA Investing LLC now owns 770,182 shares of the company’s stock valued at $2,936,535,000 after purchasing an additional 770,005 shares during the last quarter. Proficio Capital Partners LLC lifted its stake in AutoZone by 482,040.2% in the fourth quarter. Proficio Capital Partners LLC now owns 419,462 shares of the company’s stock valued at $1,343,117,000 after buying an additional 419,375 shares during the period. Price T Rowe Associates Inc. MD increased its stake in AutoZone by 5.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 324,616 shares of the company’s stock valued at $1,039,421,000 after purchasing an additional 17,518 shares in the last quarter. Norges Bank bought a new position in shares of AutoZone during the 4th quarter worth about $834,556,000. Finally, PineStone Asset Management Inc. grew its stake in shares of AutoZone by 6.9% in the 4th quarter. PineStone Asset Management Inc. now owns 213,575 shares of the company’s stock valued at $683,867,000 after buying an additional 13,771 shares during the period. 92.74% of the stock is currently owned by institutional investors.
AutoZone Trading Down 0.8 %
AZO opened at $3,746.18 on Wednesday. The stock’s fifty day simple moving average is $3,636.76 and its 200 day simple moving average is $3,389.32. AutoZone has a 1-year low of $2,728.97 and a 1-year high of $3,916.81. The stock has a market cap of $62.87 billion, a PE ratio of 25.03, a price-to-earnings-growth ratio of 1.86 and a beta of 0.44.
AutoZone (NYSE:AZO – Get Free Report) last issued its quarterly earnings data on Tuesday, March 4th. The company reported $28.29 earnings per share for the quarter, missing the consensus estimate of $29.11 by ($0.82). The company had revenue of $3.95 billion during the quarter, compared to the consensus estimate of $3.98 billion. AutoZone had a net margin of 14.18% and a negative return on equity of 53.89%. Equities analysts forecast that AutoZone will post 152.94 earnings per share for the current year.
AutoZone Company Profile
AutoZone, Inc retails and distributes automotive replacement parts and accessories in the United States, Mexico, and Brazil. The company provides various products for cars, sport utility vehicles, vans, and light trucks, including new and remanufactured automotive hard parts, maintenance items, accessories, and non-automotive products.
Featured Articles
- Five stocks we like better than AutoZone
- What Investors Need to Know to Beat the Market
- 3 Mid-Cap Medical Stocks Outperforming the Market
- Most Volatile Stocks, What Investors Need to Know
- The Top-Ranked Insider Buys From April by Market Cap
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for AutoZone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AutoZone and related companies with MarketBeat.com's FREE daily email newsletter.